0

Liver Disease Collection
 61-80 of 966 Articles
Articles |  2 March 2004
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C: A Randomized Study of Treatment Duration and Ribavirin Dose
Stephanos J. Hadziyannis, MD; Hoel Sette, MD; Timothy R. Morgan, MD; et al.
Ann Intern Med. 2004;140(5):346-355. doi:10.7326/0003-4819-140-5-200403020-00010
Reviews |  2 March 2004
Heterogeneous Virologic Response Rates to Interferon-Based Therapy in Patients with Chronic Hepatitis C: Who Responds Less Well?
Stefan Zeuzem, MD
Ann Intern Med. 2004;140(5):370-381. doi:10.7326/0003-4819-140-8-200404200-00009
Articles |  18 November 2003 FREE
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
Hashem B. El-Serag, MD, MPH; Jessica A. Davila, PhD; Nancy J. Petersen, PhD; et al.
Ann Intern Med. 2003;139(10):817-823. doi:10.7326/0003-4819-139-10-200311180-00009
Reviews |  21 October 2003
Delayed Drug Hypersensitivity Reactions
Werner J. Pichler, MD
Ann Intern Med. 2003;139(8):683-693. doi:10.7326/0003-4819-139-8-200310210-00012
Brief Communications |  16 September 2003
Hepatic Injury in 12 Patients Taking the Herbal Weight Loss Aids Chaso or Onshido
Masayuki Adachi, MD; Hidetsugu Saito, MD, PhD; Hisashi Kobayashi, MD; et al.
Ann Intern Med. 2003;139(6):488-492. doi:10.7326/0003-4819-139-6-200309160-00012
Articles |  5 August 2003
The Effect of Selective Intestinal Decontamination on the Hyperdynamic Circulatory State in Cirrhosis: A Randomized Trial
Brindhesha Rasaratnam , MBBS, FRACP; David Kaye , MBBS, FRACP, PhD; Garry Jennings , MBBS, FRACP, MD; et al.
Ann Intern Med. 2003;139(3):186-193. doi:10.7326/0003-4819-139-3-200308050-00008
Reviews |  1 July 2003 FREE
Test Characteristics of α-Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C: A Systematic Review and Critical Analysis
Samir Gupta, MD; Stephen Bent, MD; Jeffrey Kohlwes, MD, MPH
Ann Intern Med. 2003;139(1):46-50. doi:10.7326/0003-4819-139-1-200307010-00012
Articles |  15 April 2003
Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis
Elizabeth D. Morrison, MD; David J. Brandhagen, MD; Pradyumna D. Phatak, MD; et al.
Ann Intern Med. 2003;138(8):627-633. doi:10.7326/0003-4819-138-8-200304150-00008
Articles |  18 February 2003
Interferon Therapy after Tumor Ablation Improves Prognosis in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus
Yasushi Shiratori, MD; Shuichiro Shiina, MD; Takuma Teratani, MD; et al.
Ann Intern Med. 2003;138(4):299-306. doi:10.7326/0003-4819-138-4-200302180-00008
Brief Communications |  4 February 2003
Treatment of Chronic Hepatitis C in a State Correctional Facility
Scott A. Allen, MD; Anne C. Spaulding, MD; Albert M. Osei, MD; et al.
Ann Intern Med. 2003;138(3):187-190. doi:10.7326/0003-4819-138-3-200302040-00010
Editorials |  4 February 2003
Adopting More Systematic Approaches to Hepatitis C Treatment in Correctional Facilities
Theodore M. Hammett, PhD
Ann Intern Med. 2003;138(3):235-236. doi:10.7326/0003-4819-138-3-200302040-00021
Articles |  17 December 2002
Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
George Ostapowicz, MD; Robert J. Fontana, MD; Frank V. Schiødt, MD; et al.
Ann Intern Med. 2002;137(12):947-954. doi:10.7326/0003-4819-137-12-200212170-00007
Brief Communications |  17 December 2002
Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus Infection
Alfredo Alberti, MD; Franco Noventa, MD; Luisa Benvegnù, MD; et al.
Ann Intern Med. 2002;137(12):961-964. doi:10.7326/0003-4819-137-12-200212170-00009
Articles |  15 October 2002
Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial
Robert M. Jasmer, MD; Jussi J. Saukkonen, MD; Henry M. Blumberg, MD; et al.
Ann Intern Med. 2002;137(8):640-647. doi:10.7326/0003-4819-137-8-200210150-00007
Editorials |  15 October 2002
Rare Outcomes, Common Treatments: Analytic Strategies Using Propensity Scores
Leonard E. Braitman, PhD; Paul R. Rosenbaum, PhD
Ann Intern Med. 2002;137(8):693-695. doi:10.7326/0003-4819-137-8-200210150-00015
Articles |  2 July 2002
Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels
Daniele Prati, MD; Emanuela Taioli, MD, PhD; Alberto Zanella, MD; et al.
Ann Intern Med. 2002;137(1):1-10. doi:10.7326/0003-4819-137-1-200207020-00006
Editorials |  2 July 2002
Alanine Aminotransferase Levels: What's Normal?
Marshall M. Kaplan, MD
Ann Intern Med. 2002;137(1):49-51. doi:10.7326/0003-4819-137-1-200207020-00012
Academia and the Profession |  18 June 2002
Truth Survival in Clinical Research: An Evidence-Based Requiem?
Thierry Poynard, MD, PhD; Mona Munteanu, MD; Vlad Ratziu, MD; et al.
Ann Intern Med. 2002;136(12):888-895. doi:10.7326/0003-4819-136-12-200206180-00010
Reviews |  21 May 2002
Approach to the Patient with Chronic Hepatitis C Virus Infection
Steven K. Herrine, MD
Ann Intern Med. 2002;136(10):747-757. doi:10.7326/0003-4819-136-10-200205210-00010
Brief Communications |  7 May 2002
Reversibility of Cirrhosis in Patients Cured of Thalassemia by Bone Marrow Transplantation
Pietro Muretto, MD; Emanuele Angelucci, MD; Guido Lucarelli, MD
Ann Intern Med. 2002;136(9):667-672. doi:10.7326/0003-4819-136-9-200205070-00009
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)